pharma
Phase 3 failure for AstraZeneca’s Imfinzi combo in unresectable metastatic bladder cancer
March 6, 2020Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, bladder cancer, pharma, trial failure
New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …
New study calculates median drug development costs at circa $1 billion
March 5, 2020Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma
New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …
China approves Roche’s Actemra to fight severe complications stemming from coronavirus
March 5, 2020Sales and Marketing Actemra, China, Roche, coronavirus, pharma
China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …
Positive CHMP approval for Takeda’s Alunbrig in ALK+ advanced non-small lung cancer
March 4, 2020Research and Development CHMP, EMA, Takeda, lung cancer, pharma
Takeda’s Alunbrig (brigatinib) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal
March 3, 2020Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma
Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …
Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma
March 3, 2020Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma
Sanofi’s monoclonal antibody and CD-38 inhibitor Sarclisa (isatuximab-irfc) has been awarded marketing authorisation from the FDA in the treatment of …
Funding overview for the pharmaceutical industry and outlook for 2020
March 2, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma
This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …
FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim
March 2, 2020Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma
The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …
Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting
February 28, 2020Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma
UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …
The March 2020 issue of Pharmafocus is available to read free online now!
February 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes
The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
NICE recommends Celgene’s Revlimid combo for follicular lymphoma
February 27, 2020Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma
NICE has chosen to recommend Celgene’s Revlimid (lenalidomide) for use on the NHS, it has emerged, alongside Genentech’s Rituxan (rituximab), …
Female participation up in 2019 US clinical trials, but minority representation down
February 27, 2020Medical Communications, Research and Development FDA, clinical trials, pharma
The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …
US Judge rules that a decade of unpublished trial results must be made public
February 27, 2020Medical Communications, Research and Development FDA, US, clinical trials, pharma
A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …
First US coronavirus trial launched into Gilead’s remdesivir
February 26, 2020Research and Development FDA, Gilead, US, coronavirus, pharma
The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …
Scotland’s life sciences sector on track to break $8 billion by 2025
February 25, 2020Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma
A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
